Behbahani Ali Insider Trades & Stock Holdings

Director · CRISPR Therapeutics AG · Latest filing Sep 17, 2026

Behbahani Ali, Director at CRISPR Therapeutics AG has 1 Form 4 trade on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($780.94K), net -$780.94K. Latest filing: disposed of 13.68K shares of $CRSP on Sep 17, 2026 at $57.09.

Trades on file

1

Open-market bought

$0

Open-market sold

$780.94K

Net open-market

-$780.94K

Latest filing

Sep 17, 2026

All insider trades by Behbahani Ali

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 17, 2026	$CRSP	Sell (Open-market sale)	13.68K	$57.09	$780.94K			-2.8%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Behbahani Ali traded

• $CRSP

Frequently asked questions

Has Behbahani Ali been buying or selling stock?

Behbahani Ali has 0 open-market purchases and 1 open-market sale on file, net -$780.94K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Behbahani Ali's latest insider trade?

disposed of 13.68K shares of $CRSP on Sep 17, 2026 at $57.09.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.